本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tscan Therapeutics, Inc.

1.05
-0.0100-0.94%
成交量:17.26万
成交额:18.27万
市值:5,958.54万
市盈率:-1.05
高:1.09
开:1.06
低:1.05
收:1.06
52周最高:2.57
52周最低:0.8824
股本:5,674.80万
流通股本:4,403.13万
量比:1.01
换手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-1.0000
每股收益(LYR):-1.0000
净资产收益率:-71.28%
总资产收益率:-27.88%
市净率:0.48
市盈率(LYR):-1.05

数据加载中...

2022/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/09

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/24

重要事件披露

8-K - Current report
2021/12/02

重要事件披露

8-K - Current report
2021/11/10

重要事件披露

8-K - Current report
2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/19

重要事件披露

8-K - Current report
2021/08/19

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/20

重要事件披露

8-K - Current report
2021/07/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/16

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/07/14

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/13

SEC问询函

CORRESP [Cover] - Correspondence